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ABSTRACT
Eukaryotic cells contain a delicate balance of
minute amounts of the four deoxyribonucleoside
triphosphates (dNTPs), sufficient only for a few
minutes of DNA replication. Both a deficiency and
a surplus of a single dNTP may result in increased
mutation rates, faulty DNA repair or mitochondrial
DNA depletion. dNTPs are usually quantified by an
enzymatic assay in which incorporation of radio-
active dATP (or radioactive dTTP in the assay for
dATP) into specific synthetic oligonucleotides by a
DNA polymerase is proportional to the concentra-
tion of the unknown dNTP. We find that the
commonly used Klenow DNA polymerase may
substitute the corresponding ribonucleotide for the
unknown dNTP leading in some instances to a large
overestimation of dNTPs. We now describe assay
conditions for each dNTP that avoid ribonucleotide
incorporation. For the dTTP and dATP assays
it suffices to minimize the concentrations of the
Klenow enzyme and of labeled dATP (or dTTP); for
dCTP and dGTP we had to replace the Klenow
enzyme with either the Taq DNA polymerase or
Thermo Sequenase. We suggest that in some
earlier reports ribonucleotide incorporation may
have caused too high values for dGTP and dCTP.
INTRODUCTION
DNA replication and repair require each of the four
canonical deoxyribonucleoside triphosphates (dNTPs).
The relative amount of each dNTP is important for
correct DNA synthesis (1–4). Genetic diseases result
from mutations in anabolic enzymes (5,6) leading to deﬁ-
ciency of one or the other dNTP, and also from mutations
in catabolic enzymes (2,7,8) resulting in the excess of one
or several dNTPs. In recent years interest in the determi-
nation of dNTPs in cell extracts has increased greatly,
stimulated by discoveries that have shifted the focus
from the needs of nuclear DNA replication during
S phase to the requirements of mitochondrial DNA
maintenance in diﬀerentiated cells (9). In addition, the
discovery that ribonucleotide reduction takes place also
outside S phase (10,11) is inducible by DNA damage
(12) and is a limiting source of dNTPs for mitochondrial
DNA synthesis in quiescent cells (13) has highlighted the
importance of measuring dNTPs in non-proliferating cells
or in mitochondria. The sizes of the dNTP pools shrink
about 10-fold as cells stop cycling and mitochondrial
pools, which correspond to less than 10% of the overall
cellular pools (14), reach levels below 1pmol per million
cells. Thus a sensitive and reliable method for the deter-
mination of minute amounts of dNTPs in cell extracts
becomes indispensable to understand the mechanisms of
nuclear and mitochondrial DNA replication and repair
(15), mutagenesis (16) and apoptosis (17) and detect
changes in the dNTP pools in genetically manipulated
cells (18) and animal models of human diseases (19,20).
dNTPs in extracts from cultured cells or animal organs
are usually quantiﬁed by two independent methods:
high-performance liquid chromatography (HPLC)
(10,21,22) or an enzymatic assay with a DNA polymerase
(23,24). Each method has its problems and ideally both
should be used in parallel. Often the small amounts of
dNTPs in the extracts prohibit the use of HPLC and the
more sensitive enzymatic assay then becomes the method
of choice. More recently, highly sensitive LC-MS/MS
methods were introduced (25,26). Unfortunately they are
unsuitable for measurements of dCTP and dGTP (25) or
dGTP (26) and thus do not provide the required spectrum
of all four dNTPs. An additional weakness is that the
speciﬁc radioactivity of dNTPs in isotope experiments
cannot be measured.
The enzymatic method is based on the incorporation of
labeled dATP (or dTTP) into deﬁned synthetic
oligonucleotides by a DNA polymerase (usually the
Escherichia coli Klenow fragment). The oligonucleotides
used for each dNTP are constructed such that the incor-
poration of labeled dATP (or dTTP) is proportional to the
amount of the dNTP to be determined (23). As an
example, Figure 1 shows the structure of the
oligonucleotide for the dCTP assay. Elongation of the
primer strand requires dCTP with the incorporation of
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labeled dATPs. From the radioactivity incorporated into
the oligomer and a standard curve with known amounts of
non-radioactive dCTP one can then calculate the con-
centration of dCTP in the sample to be analyzed. In
model experiments as little as 0.1pmol of dCTP can be
determined with great accuracy. The validity of the assay
depends on the speciﬁcity of the polymerase, i.e. only
dCTP should promote the incorporation of radioactive
dATP. When dNTPs are analyzed in cell extracts,
however, the speciﬁcity of the assay may be compromised
by interfering nucleotides. Speciﬁcity rests not only on the
selection of the correct dNTPs through base pairing with
the template strand, but also on the ability of the
polymerase to distinguish between nucleotides contain-
ing sugars other than deoxyribose. In particular
ribonucleoside triphosphates (rNTPs) provide a complica-
tion in this respect.
We observed a lack of proportionality in the incorpo-
ration of labeled dATP in assays with diﬀerent aliquots of
extracts from quiescent cultured ﬁbroblasts containing
very small dNTP pools. When we attempted to increase
the sensitivity of the enzymatic assay by increasing the
concentration of the polymerase we obtained unrealisti-
cally high dNTP values (our unpublished data). At this
point we remembered that already in the 1960s it was
reported that the E. coli DNA polymerase could substitute
rNTPs for dNTPs (27), with CTP and GTP being partic-
ularly eﬀective (28). Incorporation was pronounced when
Mn
2+ replaced Mg
2+ in the reaction. Subsequently it was
shown (29) that the Klenow fragment of the polymerase
used in our assays has a limited speciﬁcity for deoxyribose
also in the presence of Mg
2+. We set out to study this
problem in detail to ﬁnd dNTP assay conditions without
interference by ribonucleotides. Here we describe the
results of these studies. We found that both dATP and
dTTP could be determined with the Klenow fragment,
provided care was taken to limit the concentration of
the enzyme. For dCTP and dGTP also limiting concentra-
tions of the Klenow enzyme led to erroneously high
values. These two nucleotides could instead be assayed
by substituting the Klenow enzyme by either Taq DNA
polymerase or Thermo Sequenase.
MATERIALS AND METHODS
Enzymes
The Klenow fragment of the E. coli DNA polymerase I
used in the assays described in ‘Results’ section was from
Invitrogen (Life Science, San Giuliano Milanese, Italy).
Other preparations of the Klenow enzyme were from
Biolabs (Celbio, Pero, Italy) or Promega (Milano, Italy).
The E. coli DNA polymerase I was from Promega.
Taq DNA polymerase and Thermo Sequenase DNA
Polymerase with Thermoplasma acidophilum inorganic
pyrophosphatase was from GE Healthcare (Little
Chalfont, UK).
Enzymatic assays, general conditions
The general conditions for the assays were those described
by Sherman and Fyfe (23), including the preparation of
the speciﬁc oligonucleotides used for each of the four
dNTPs. We used, however, a 10-fold lower concentration
of labeled dATP or dTTP. Brieﬂy, the reaction mixture
contained, in a volume of 0.1ml, 0.1–4pmol of the dNTP
to be determined together with 40mM Tris-HCl, pH 7.4,
10mM MgCl2, 5mM dithiothreitol, 0.25mM oligo-
nucleotide, 1.5mg RNase A, 0.25mM labeled dATP,
500–1000cpm/pmol (or labeled dTTP for the dATP
assay) and DNA polymerase. RNase A was included in
the assay to remove any labeled RNA formed in metabolic
experiments with
3H- labeled nucleosides. The nature and
the amount of the DNA polymerase used in the assay
are given below for each separate dNTP determination.
After 60min incubation 0.085ml of the mix was spotted
on circular disks of Whatman DE81 paper. After drying,
the ﬁlters were washed three times for 10minin large
volumes of 5% Na2HPO4, once in distilled water and
once in absolute ethanol. The retained radioactivity was
determined by scintillation counting.
Enzyme concentrations for the diﬀerent dNTPs
We used limiting amounts of the Klenow enzyme for
dTTP and dATP assays and the Taq DNA polymerase
for dCTP and dGTP assays. The chosen enzyme concen-
tration must be balanced by the requirement of a close
to linear dose–response curve in the range of the dNTP
concentrations to be analyzed. It is advisable to test each
new batch of enzyme to ﬁnd the smallest amount of
enzyme that for a given dNTP suﬃces to give a close
to linear standard curve between 0.1 and 4pmol of the
dNTP. We found this range to be optimal for the
analysis of dNTPs present in cell extracts. For our
Klenow enzyme 0.2 units suﬃced for the dTTP assay
and 0.025 units for the dATP assay, with 60min incuba-
tion at 37 C. For Taq DNA polymerase 2 units were
required for both dCTP and dGTP, with 60min incuba-
tion at 48 C. Once standardized, we used each batch of
enzyme for months without change of conditions and
without interference by rNTPs.
Cell extracts for dNTP assays
For the experiment described in Table 1 we prepared
extracts from cycling and conﬂuent normal human skin
ﬁbroblasts, grown in DMEM with Earle salts and
glutamine and 10% fetal bovine serum (Invitrogen).
Cultures were started at 0.3 million cells/10cm dish with
fresh medium being supplied twice weekly. Cycling
cells were harvested after 48h growth (14% S-phase,
Figure 1. Enzymatic assay for dCTP. During incubation with a speciﬁc
oligonucleotide template a DNA polymerase incorporates three mole-
cules of labeled dATP for each dCTP converting them into an
acid-insoluble form. The amount of dCTP is calculated from the
incorporated radioactivitiy in a standard curve with known amounts
of dCTP.
e85 Nucleic Acids Research, 2010,Vol. 38,No. 6 PAGE 2 OF 7determined by ﬂuorescence-activated ﬂow cytometry),
conﬂuent cells were harvested after 14 days in culture
(1.8% S-phase). Dishes were cooled on ice, the cells were
carefully washed free of medium and extracted with
2ml/dish of ice-cold 60% methanol (8). After immersion
for 3minina boiling water bath the methanolic extract
was centrifuged and brought to dryness by centrifugal
evaporation. The dry residue was dissolved in 0.2ml of
water and used for assays. We analyzed routinely two
aliquots of diﬀerent size per each sample to ascertain
linearity of the assay.
HPLC chromatography
The eight canonical rNTPs and dNTPs were separated on
a WAX weak anion exchange column (PolyLC, DTO
Servizi, Spinea, Italy) by isocratic elution with 0.32M
KH2PO4, pH 5.0, containing 3% acetonitrile (ﬂow rate
0.5ml/min) (10). We found the following retention times
(in min):dTTP, 15.8; UTP,18.8;dCTP, 25.1; CTP, 29.2;
dATP, 35.4; ATP, 40.5; dGTP, 71.2 and GTP 83.4.
Peaks in cell extracts could be identiﬁed from their posi-
tions and from their relative absorbances at 260 and
280nm. When analyzed by HPLC the rNTPs used in the
model experiments contained no detectable dNTPs.
RESULTS
CTP replaces dCTP for the Klenow polymerase
We substituted CTP for dCTP in an experiment with the
oligonucleotide shown in Figure 1 to test if the
ribonucleotide would promote the incorporation of
labeled dATP. Figure 2 shows one of several typical exper-
iments in which we measured the ability of 50 or
1000pmol of CTP to support DNA replication in the
absence of dCTP. The two amounts of CTP correspond
approximately to those present in the aliquots of extracts
from cycling or conﬂuent cultured cells used for dCTP
assays as described below in Table 1. In the ordinate
of Figure 2 we have transformed the incorporated radio-
activity into apparent pmol of dCTP calculated from a
parallel standard curve with known amounts of dCTP.
Incorporation of radioactivity increased not only with
the amount of CTP, but also with the amount of the
polymerase and to a somewhat lesser extent with that of
labeled dATP. Thus, at the lower enzyme and dATP con-
centrations, 50pmol CTP mimicked the presence of
almost 1pmol of dCTP whereas 1000pmol mimicked
3pmol. At the higher dATP and enzyme concentrations
the apparent dCTP increased to 3 and 20pmol, respec-
tively. These data clearly show that with the Klenow
polymerase the assay of dCTP in cell extracts might be
seriously ﬂawed by the presence of CTP. We obtained
similar results when GTP or ATP was tested in place of
CTP in the absence of the cognate deoxynucleotide
(data not shown).
rNTPs contribute to dNTP assays by the Klenow
polymerase
We found that rNTPs in amounts present in cell extracts
increased the incorporation of labeled dATP (dTTP in the
case of ATP) into oligonucleotides during assays of
dNTPs, leading to erroneously high values for the
dNTPs. The magnitude of the eﬀect depended on the
concentrations of the rNTP, the enzyme, and the labeled
dATP. Each rNTP/dNTP pair showed in principle this
behavior, but with considerable individual quantitative
diﬀerences. Figure 3 shows typical model experiments
with known amounts of standard nucleotides for each
rNTP/dNTP pair. In these and other nonpublished
experiments the concentrations of CTP, GTP and UTP
were two or three orders of magnitude in excess over the
corresponding dNTPs and that of ATP four orders of
magnitude. In all cases CTP (Figure 3A) and GTP
(Figure 3B) at higher concentration gave the largest dis-
turbances with an up to 10-fold increased value for dCTP
and a 4-fold increase for dGTP, respectively. The data in
Figure 3A and B were obtained with 0.2 units of enzyme.
In additional experiments we tested diﬀerent concentra-
tions of polymerase and dNTPs, and again found interfer-
ence by CTP and GTP (data not shown). The eﬀects
of UTP (Figure 3C) and ATP (Figure 3D) were smaller
and minimal at the lowest enzyme concentration.
Three diﬀerent commercial preparations of the Klenow
enzyme and one preparation of E. coli DNA polymerase
I were investigated with similar results, albeit with minor
quantitative diﬀerences (data not shown). From these
results we conclude that the Klenow enzyme is not
suitable for dCTP and dGTP assays but can be used for
the assay of dTTP and dATP. With these two dNTPs,
care must be taken to determine in preliminary model
experiments a concentration of Klenow polymerase
suﬃciently low to avoid the interference by the rNTPs.
One must of course also ensure that the enzyme
concentration gives an appropriate standard curve in the
desired dTTP and dATP concentration range. The
Figure 2. CTP replaces dCTP during assay with the Klenow DNA
polymerase. In the absence of dCTP we incubated CTP (50 or
1000pmol) with the Klenow enzyme (0.2 or 1 unit) together with
labeled dATP (0.25 or 2.5mM) as described in ‘Materials and
Methods’ section and determined the incorporation of radioactivity
into the oligonucleotide shown in Figure 1. The recovered
acid-insoluble radioactivity was transformed into apparent pmol
dCTP (ordinate) as calculated from a parallel standard curve with
known amounts of dCTP.
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per 0.1ml assay volume. We found this to be an excess.
With our commercial Klenow enzyme we determined
0.025 units to be optimal for the dATP assay and 0.2
units for dTTP.
Taq DNA polymerase or Thermo Sequenase are suitable
for dCTP and dGTP assays
The discrimination of the Klenow polymerase between the
ribo- and deoxyribonucleotides of guanine and cytosine
was not suﬃcient to permit the use of the enzyme to
assay dCTP and dGTP. We therefore turned to other
DNA polymerases and tested their suitability. We found
that both Taq DNA polymerase and Thermo Sequenase
showed the required discrimination. Figure 4A and B
report representative dCTP and dGTP assays, respec-
tively, with Taq DNA polymerase. In both cases the
addition of the ribotides in 100- or 1000-fold excess over
two concentrations of the corresponding dNTPs only
marginally aﬀected the result of the assays. Figure 4C
shows a similar experiment with the Thermo Sequenase
in a dGTP assay in the presence of a 200–1000-fold
excess of GTP. These experiments were not run at the
optimal temperature of the thermostable enzymes but at
48 C to avoid melting of the oligonucleotide primers.
Comparison of dNTP determinations in cell extracts by
diﬀerent assays
To establish the validity of the ‘new’ DNA polymerase
assay we extracted dNTP pools from cycling and conﬂu-
ent human ﬁbroblasts in culture and determined all four
dNTP pools by the polymerase assay with the Klenow
enzyme as described in the original communication (23)
and by the new method described here (Table 1).
In cycling cells we also determined rNTPs and dNTPs
by a HPLC method that separates all eight ribo- and
deoxyribonucleoside triphosphates (10). By the same pro-
cedure we measured rNTPs in extracts from conﬂuent
cells. Here the concentration of dNTPs was too low to
be measured with accuracy by HPLC due to interference
by unknown peaks and neighboring rNTPs. For dNTPs
in cycling cells the agreement between HPLC and the
new polymerase assay was excellent (Table 1). In
contrast, the original method gave twice the amount
of dCTP and dGTP, a small increase of dATP and no
diﬀerence for dTTP. These relations agree with the
Figure 3. Eﬀect of rNTPs on the recovery of dNTPs in assays with the Klenow polymerase. (A) CTP (at 100- or 1000-fold higher concentration than
dCTP) in dCTP (0.5 or 1pmol) assay with 0.2 units of enzyme and either 0.25 or 2.5mM labeled dATP. The ordinate shows the increased apparent
recovery of dCTP in the assay, due to misincorporation of CTP in the polymer. (B) GTP in dGTP assay. Conditions as in A. (C) UTP in dTTP
assay. We tested two enzyme concentrations (0.2 and 1 unit) at 0.25mM labeled dATP. Other conditions as in A. Very similar values for dTTP
recovery were obtained also with 200- and 2000-fold excess UTP. (D) ATP in dATP assay. Quantitation of dATP (0.5 or 1pmol) in the presence of
5000pmol ATP and 0.25mM labeled dTTP at various enzyme concentrations (0.025, 0.05 or 0.2 units).
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experiments of Figure 3. Turning now to the conﬂuent
cells we notice ﬁrst that all four dNTP pools were about
10 times smaller than in cycling cells. The four
ribonucleoside triphosphates in contrast decreased only
less than half. The discrepancy between the ‘old’ and
new assays is now larger. The values in the ‘old’ assay
are more than 3-fold larger for dCTP and dGTP and
also dATP is 2-fold increased whereas the amount of
dTTP is the same. The larger diﬀerences between the
two methods in conﬂuent cells reﬂect these cells’ higher
rNTP/dNTP ratios that enhance the unspeciﬁc rNTP
incorporation in the oligonucleotide by the Klenow
polymerase.
DISCUSSION
The concentration of the four dNTPs in eukaryotic cells is
very low and undergoes large variations with the cell cycle,
as illustrated here by the results in Table 1. Comparisons
of pool sizes from normal cells with those of cells whose
nuclear or mitochondrial DNA synthesis is compromised
by mutations, genetic manipulations or diseases involve
both logistic and analytical problems. One very important
logistic problem that unfortunately is not always consid-
ered is to choose cell populations in equal growth phases
for a comparison.
In this article we address an important analytical
problem arising from the lack of speciﬁcity of the DNA
polymerase in the enzymatic assay for the determination
of dNTPs. The polymerase generally used for the assays is
the Klenow DNA polymerase, together with
oligonucleotides speciﬁcally designed for the assay of
each dNTP (23). We found in model experiments that
this enzyme to a small extent can substitute rNTPs for
dNTPs for incorporation into the oligonucleotide.
The degree of misincorporation diﬀers for the four
ribonucleotides. For each rNTP the major factors
determining the extent of misincorporation were (i) the
inherent speciﬁcity of the polymerase for the dNTP (ii)
the concentration of the enzyme in the assay and (iii) the
concentration of the rNTP in the sample relative to that
of the dNTP.
In our model experiments with known amounts of
standard nucleotides the inherent speciﬁcity of the
Klenow enzyme was high for dTTP and lowest for
dCTP and dGTP, with dATP occupying an intermediate
position. These data fully agree with the earliest results
concerning a low speciﬁcity of the E. coli DNA
polymerase for dCTP and dGTP in the presence of
Mn
2+ (27) and later similar results with various
polymerases and Mg
2+(30,31). In these experiments the
inherent speciﬁcity of the Taq DNA polymerase was
almost 10 times higher than that of the Klenow
enzyme (31).
Figure 4. Assays of dCTP and dGTP with Taq DNA polymerase or Thermo Sequenase. (A) Eﬀect of CTP (100- or 1000-fold excess) in dCTP (0.5
or 1pmol) assay at 0.25mM dATP with 2 units Taq DNA polymerase. (B) GTP in dGTP assay. Conditions as in A. (C) Thermo Sequenase in dGTP
assay. dGTP (0.2–1pmol) was assayed with 2 units Thermo Sequenase in the presence of 200pmol GTP. General conditions as in Figure 2.
Table 1. Deoxyribonucleoside and ribonucleoside triphosphates in
extracts from cycling and conﬂuent human ﬁbroblasts. dNTPs were
determined by the original enzymatic method (23), by the enzymatic
method described here or by HPLC. rNTPs were measured by
HPLC. The numbers represent pmol of each nucleotide per million
cells
(d)ATP (d)GTP dTTP(UTP) (d)CTP
Cycling cells, dNTPs
Original assay 57 32 92 89
New assay 47 18 92 44
HPLC 45 18 103 44
Cycling cells, rNTPs 15200 2600 4000 1650
rNTP/dNTP ratio 350 140 40 40
Conﬂuent cells, dNTPs
Original assay 17 6 8 18
New assay 8 1.2 8 6
Conﬂuent cells, rNTPs 11600 2400 2800 970
rNTP/dNTP ratio 1450 2000 350 160
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reaction we could completely avoid misincorporation of
UTP or ATP and use the Klenow enzyme for assays of
dTTP and dATP. This expedient was not eﬀective for
dCTP and dGTP and in these assays we had to substitute
the Klenow enzyme with either Taq DNA polymerase or
Thermo Sequenase. These two polymerases have a higher
speciﬁcity for dNTPs but their concentrations must again
be limited as at higher concentrations they also showed
a tendency to incorporate rNTPs (our unpublished data).
The third factor that inﬂuenced the degree of
misincorporation is the rNTP/dNTP ratio in the cell
extract. In conﬂuent human ﬁbroblasts this ratio is very
large, ranging from 160 for CTP/dCTP to 2000 for
GTP/dGTP (Table 1) and may favor extensive
misincorporation during the assay of dGTP.
These three factors limit the usefulness of the original
DNA polymerase assay that under adverse circumstances
may erroneously give a biased composition of the four
dNTP pools, with a correct value for dTTP but a large
overrepresentation of dCTP and dGTP. In particular cells
and organelles with small dNTP pools are prone to suﬀer
from this bias (cf Table 1). We believe that this
may explain exceedingly high dGTP/dTTP ratio in
mitochondria from rat organs (32) obtained with the
polymerase assay. Such a skewed ratio could not be
conﬁrmed later (24) by HPLC analysis of mouse liver
mitochondria.
In conclusion the modiﬁcations introduced here into the
enzymatic assay should make it possible to avoid a major
obstacle in the determination of the four canonical dNTPs
which may lead to an overestimation of pool sizes. In
general the DNA polymerase assay for dNTPs is used to
provide still images of pool sizes of individual dNTPs.
We wish to emphasize that the method also permits, in
combination with isotope-ﬂow experiments, to follow
dynamics of dNTP pools, such as pool turnover,
exchange of pool components between mitochondria and
cytosol and in situ reaction rates (18,33).
FUNDING
Associazione Italiana per la Ricerca sul Cancro (to V.B.);
Italian Telethon (grant GGP05001), Fondazione Cassa di
Risparmio di Padova e Rovigo and the University of
Padova (Progetti Strategici di Ateneo).
Conﬂict of interest statement. None declared.
REFERENCES
1. Meuth,M. (1989) The molecular basis of mutations induced by
deoxyribonucleoside triphosphate pool imbalances in mammalian
cells. Exp.Cell Res., 181, 305–316.
2. Weinberg,G., Ullman,B. and Martin,D.W. Jr (1981) Mutator
phenotypes in mammalian cell mutants with distinct biochemical
defects and abnormal deoxyribonucleoside triphosphate pools.
Proc. Natl Acad. Sci. USA, 78, 2447–2451.
3. Reichard,P. (1988) Interactions between deoxyribonucleotide and
DNA synthesis (1988) Annu. Rev. Biochem., 57, 349–374.
4. Kunz,B.A., Kohalmi,S.E., Kunkel,T.A., Mathews,C.K.,
MacIntosh,E.M. and Reidy,I.A. (1994) Deoxyribonucleoside
triphosphate levels: a critical factor in the maintenance of genetic
stability. Mutat. Res., 318, 1–64.
5. Spinazzola,A. and Zeviani,M. (2005) Disorders of
nuclear-mitochondrial intergenomic signaling. Gene, 354, 162–168.
6. Saada,A. (2004) Deoxyribonucleotides and disorders of
mitochondrial DNA integrity. DNA and Cell Biol., 23, 797–806.
7. Nishino,I., Spinazzola,A. and Hirano,M. (1999) Thymidine
phosphorylase gene mutations in MNGIE, a human
mitochondrial disorder. Science, 283, 689–692.
8. Pontarin,G., Ferraro,P., Valentino,M.L., Hirano,M., Reichard,P.
and Bianchi,V. (2006) Mitochondrial DNA depletion and
thymidine phosphate pool dynamics in a cellular model of
mitochondrial neurogastrointestinal encephalomyopathy. J. Biol.
Chem., 281, 22720–22728.
9. Copeland,W.C. (2008) Inherited mitochondrial diseases of DNA
replication. Annu. Rev. Med., 59, 131–146.
10. Ha ˚ kansson,P., Hofer,A. and Thelander,L. (2006) Regulation
of mammalian ribonucleotide reduction and dNTP pools
after DNA damage and in resting cells. J. Biol. Chem., 281,
7834–7841.
11. Pontarin,G., Ferraro,P., Ha ˚ kansson,P., Thelander,L., Reichard,P.
and Bianchi,V. (2007) p53R2-dependent ribonucleotide reduction
provides deoxyribonucleotides in quiescent human ﬁbroblasts in
the absence of induced DNA damage. J. Biol. Chem., 282,
16820–16828.
12. Tanaka,H., Arrakawa,H., Yamaguchi,T., Shiraishi,K. and
Fukuda,S. (2000) A ribonucleotide reductase gene involved in a
p53-dependent cell-cycle checkpoint for DNA damage. Nature,
404, 42–49.
13. Bourdon,A., Minai,L., Serre,V., Jais,J.P., Sarzi,E., Aubert,S.,
Chre ´ tien,D., de Lonay,P., Paquis-Flucklinger,V., Arakawa,H.
et al. (2007) Mutation of RRM2B, encoding p53-controlled
ribonucleotide reductase (p53R2), causes severe mitochondrial
DNA depletion. Nat. Genet., 39, 776–780.
14. Ferraro,P., Pontarin,G., Crocco,L., Fabris,S., Reichard,P. and
Bianchi,V. (2005) Mitochondrial deoxynucleotide pools in
quiescent ﬁbroblasts. A possible model for mitochondrial
neurogastrointestinal encephalomyopathy (MNGIE). J. Biol.
Chem., 280, 24472–24480.
15. Chabes,A., Georgieva,B., Domkin,V., Zao,X., Rothstein,R. and
Thelander,L. (2003) Survival of DNA damage in yeast directly
depends on increased dNTP levels allowed by relaxed feedback
inhibition of ribonucleotide reductase. Cell, 112, 391–401.
16. Chabes,A. and Stillman,B. (2007) Constitutively high dNTP
concentration inhibits cell cycle progression and the DNA
damage checkpoint in yeast Saccharomyces cerevisiae. Proc. Natl
Acad. Sci. USA, 104, 1183–1188.
17. Kim,H.-E., Du,F., Fang,M. and Wang,X. (2005) Formation of
apoptosome is initiated by cytochrome c-induced dATP hydrolysis
and subsequent nucleotide exchange on Apaf-1. Proc. Natl Acad.
Sci. USA, 102, 17545–17550.
18. Rampazzo,C., Fabris,S., Franzolin,E., Crovatto,K., Frangini,M.
and Bianchi,V. (2007) Mitochondrial thymidine kinase and the
enzymatic network regulating thymidine triphosphate pools in
cultured human cells. J. Biol. Chem., 282, 34758–34769.
19. Akman,H.O., Dorado,B., Lo ´ pez,L.C., Garcı´a-Cazorla,A.,
Vila ` ,M.R., Tanabe,L.M., Dauer,W.T., Bonilla,E., Tanji,K. and
Hirano,M. (2008) Thymidine kinase 2 (H126N) knockin mice
show the essential role of balanced deoxynucleotide pools for
mitochondrial DNA maintenance. Hum. Mol. Genet., 17,
2433–2440.
20. Lo ´ pez,L.C., Akman,H.A., Garcı´a-Cacorla,A., Dorado,B.,
Martı`,R., Nishino,I., Tadesse,S., Pizzorno,G., Shungu,D.,
Bonilla,E. et al. (2009) Unbalanced deoxynucleotide pools cause
mitochondrial DNA instability in thymidine
phosphorylase-deﬁcient mice. Hum. Mol. Genet., 18, 714–722.
21. Garett,C. and Santi,D.V. (1979) A rapid and sensitive high
pressure liquid chromatography assay for deoxyribonucleoside
triphosphates in cell extracts. Anal. Biochem., 99, 268–273.
22. Tanaka,K., Yoshioka,A., Tanaka,S. and Wataya,Y. (1984) An
improved method for the quantitative determination of
deoxyribonucleoside triphosphates in cell extracts. Anal. Biochem.,
139, 35–41.
e85 Nucleic Acids Research, 2010,Vol. 38,No. 6 PAGE 6 OF 723. Sherman,P.A. and Fyfe,J.A. (1989) Enzymatic assay for
deoxyribonucleoside triphosphates using synthetic oligonucleotides
as template primers. Anal. Biochem., 180, 222–226.
24. Ferraro,P., Nicolosi,L., Bernardi,P., Reichard,P. and Bianchi,V.
(2006) Mitochondrial deoxynucleotide pool sizes in mouse liver
and evidence for a transport mechanism for thymidine
monophosphate. Proc. Natl Acad. Sci. USA, 103, 18586–18591.
25. Hennere ´ ,G., Becher,F., Pruvost,A., Goujard,C., Grassi,J. and
Benech,H. (2003) Liquid chromatography-tandem mass
spectrometry assays for intracellular deoxribonucleotide
triphosphate competitors of nucleoside antiretrovirals.
J. Chromatogr., 789, 273–281.
26. Chen,P., Liu,Z., Liu,X., Xie,Z., Aimiuwu,J., Pnag,J., Klisovic,R.,
Blum,W., Grever,M.R., Marcussi,G. et al. (2009) A LC-MS/MS
method for the analysis of intracellular nucleoside triphosphate
levels. Pharm. Res., 26, 1504–1515.
27. Berg,P., Fancher,H. and Chamberlin,M. (1963) Symposium on
Informational Macromolecules. Academic Press, New York,
p. 467.
28. van de Sende,J.H., Loewen,P.C. and Khorana,H.G. (1972)
Studies on polynucleotides CXVIII. A further study of
ribonucleotide incorporation into deoxyribonucleic acid chains by
deoxyribonucleic acid polymerase I of Escherichia coli. J. Biol.
Chem., 247, 6140–6148.
29. Joyce,C.M. (1997) Choosing the right sugar: how polymerases
select a nucleotide substrate. Proc. Natl Acad. Sci. USA, 94,
1619–1622.
30. Astatke,M., Kimmie,Ng., Grindley,N.G.F. and Joyce,C.M. (1998)
A single side chain prevents Escherichia coli DNA polymerase I
(Klenow fragment) from incorporating ribonucleotides. Proc. Natl
Acad. Sci. USA, 95, 3402–3407.
31. Patel,P.H. and Loeb,L.A. (2000) Multiple amino acid
substitutions allow DNA polymerases to synthesize RNA. J. Biol.
Chem., 275, 40266–40272.
32. Song,S., Pursell,Z.F., Copeland,W.C., Longley,M.J., Kunkel,T.A.
and Mathews,C.K. (2005) DNA precursor asymmetries in
mammalian tissue mitochondria and possible contribution to
mutagenesis through reduced replication ﬁdelity. Proc. Natl Acad.
Sci. USA., 102, 4990–4995.
33. Gazziola,C., Ferraro,P., Moras,M., Reichard,P. and Bianchi,V.
(2001) Cytosolic high-Km 50-nucleotidase and 5’(3’)-
deoxyribonucleotidase in substrate cycles involved in nucleotide
metabolism. J. Biol. Chem., 276, 6185–6190.
PAGE 7 OF 7 Nucleic AcidsResearch, 2010, Vol.38,No. 6 e85